Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB08895_DB08904_nanopub.RAq-ThNwwPWPSGKz89nZxnsKAcKfYtqiagS7k7xNyAnBY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB08895_DB08904 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB08895_DB08904 label "DDI between Tofacitinib and Certolizumab pegol - Certolizumab (and other anti-TNF immunosuppressants), when used in combination with tofacitinib, may increase the risk of added immunosuppression. It is recommended to avoid concurrent therapy. [drugbank_resource:DB08895_DB08904]" assertion.
- drugbank_resource:DB08895_DB08904 identifier "drugbank_resource:DB08895_DB08904" assertion.
- drugbank_resource:DB08895_DB08904 title "DDI between Tofacitinib and Certolizumab pegol - Certolizumab (and other anti-TNF immunosuppressants), when used in combination with tofacitinib, may increase the risk of added immunosuppression. It is recommended to avoid concurrent therapy." assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB08895_DB08904 assertion.
- drugbank:DB08904 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB08895_DB08904 assertion.